US Patent Litigations are now available. Check here

IP Verse

(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof

PatentPatent Analysis

EP2962690

AMGEN EUROPE
Application Number
EP15177140A
Filing Date
Mar 20, 2003
Status
Revoked
Jan 22, 2025
Grant Date
Jan 16, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2651400B2
EP3320902B1
EP2797581B1

Biblio Summary

The patent EP2962690B1 was granted on Jan 16, 2019 by Amgen Europe The patent is currently Revoked.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2962690B1
 N/A
OppositionUS6020358
 N/A
OppositionEP1752148
 N/A
OppositionWO0025777
 N/A
OppositionWO03080049
 N/A
OppositionUS6025376
 N/A
OppositionEP1485087
 N/A
OppositionEP2074995
 N/A
OppositionEP6023050
 N/A
OppositionUS366515
 N/A
OppositionEP0238044
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents